IDEAYA Biosciences IDYA
$25.56 −$0.61 (-2.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.56 0.00%
Open$25.83
Prev close$26.17
Day range$25.46 – $26.87
Volume1.11M
Market cap$2.47B
P/E (TTM)–
Dividend yield–
IDYA Stock News
Headlines matching IDEAYA Biosciences or the IDYA ticker, most recent first.
- Guggenheim Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Raises Target Price to $57 Positive
- LifeSci Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $58
- Citi Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $65
- Truist Financial Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating
- Mizuho Securities Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $50
- Citizens JMP Initiates IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $42
- Wedbush Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Raises Target Price to $60 Positive
- RBC Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $48
- A Quick Look at Today's Ratings for IDEAYA Biosciences(IDYA.US), With a Forecast Between $48 to $60
- Truist Financial Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Cuts Target Price to $59 Negative
- Wedbush Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $60
- J.P. Morgan Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Cuts Target Price to $62 Negative
- Truist Financial Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $63
- RBC Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Cuts Target Price to $48 Negative
- LifeSci Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $62
No comments yet — be the first to weigh in on IDYA.
Sign in to join the discussion.